Author: Jacob Cuyler
Jacob is on the Ph.D. track at the University of Pittsburgh and focused on Medicinal Chemistry research with a specific interest in rationalized drug design and development. He enjoys scientific writing and has contributed/ edited manuscripts. Having interned at a biotech start-up in upstate NY, he likes to stay current on trends in the sector. “Biotech Metro is a great cause as gender disparity is still present in the sciences and academia”.
In order to properly track and control the spread of COVID-19, we must develop diagnostic tests with high-throughput capabilities and excellent accuracy. Many politicians have used the term “flatten the curve” to note that it appears our infection rate is declining. States are beginning to ease economic restrictions while maintaining social distancing. With the data provided it does appear that the curve is flattening, but we still are lacking in testing capabilities. Only a small portion of people have been tested, as of May 13th there were 1.2 million individuals tested for COVID-19 in the state of New York. New…
We find ourselves in an unprecedented time as social distancing has taken full effect throughout most of the country. Some cities/states are beginning to ease their restrictions, but is it far too early to begin this process? There are no Food and Drug administration (FDA) approved vaccinations or treatments for COVID-19 and there are hotspots across the country where cases of the virus are still high. Do cities and states run the risk of creating an even bigger outbreak if we open up too early? As of May 4th, the New York City (NYC) Department of Health reported over 170,000…
Biotech Metropolitan Women ©2018-2023